Data Sheet 1_The effectiveness and safety of oral Chinese patent medicines in treating myo

A systematic review and Bayesian network meta-analysis of 42 randomized controlled trials (RCTs) evaluating 12 oral Chinese patent medicines combined with conventional treatment for myocardial infarction complicated by heart failure. The dataset includes results for 6 outcome indicators and adverse reactions, compiled by author Yiying Liu and last updated in May 2026. The analysis was registered with PROSPERO (CRD420251234570).

Use Cases

• Compare the relative effectiveness of 12 different oral Chinese patent medicines based on the reported outcome indicators.
• Analyze the impact of combined therapies on cardiac function metrics like LVEF, LVESD, and LVEDD mentioned in the results.
• Assess the safety profile and tolerability of adjunctive Chinese patent medicines for MI-HF based on the reported adverse reactions.
• Validate or extend the network meta-analysis findings using the underlying trial data structure implied by the description.

Strengths

• Includes data from 42 randomized controlled trials, providing a substantial evidence base.
• Evaluates 12 distinct interventions and 6 outcome indicators, allowing for multi-faceted comparison.
• Uses a Bayesian network meta-analysis methodology, a recognized statistical approach for comparative effectiveness.

Limitations

• The core data (trial results) are embedded within a PDF report; column-level documentation and raw data are unavailable.
• Row count and specific data structure are unknown, which limits suitability assessment for direct computational analysis.
• The description notes that poor reporting in the original studies limits definitive safety conclusions.

Provenance

Source

Systematic review of RCTs from databases including CNKI, WanFang, VIP, SinoMed, PubMed, EMbase, Web of Science, and the Cochrane Library.

Collection Method

Computerized literature search and Bayesian network meta-analysis of included studies.

Time Range

RCTs published from database inception until October 15, 2025.

Freshness

Last updated 2026-05-21 05:44:14.

Geography

null